This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ASM journals
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taudorf, S.
Right arrow Articles by Møller, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taudorf, S.
Right arrow Articles by Møller, K.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, March 2007, p. 250-255, Vol. 14, No. 3
1071-412X/07/$08.00+0     doi:10.1128/CVI.00380-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Human Models of Low-Grade Inflammation: Bolus versus Continuous Infusion of Endotoxin{triangledown}

S. Taudorf,* K. S. Krabbe, R. M. G. Berg, B. K. Pedersen, and K. Møller

Centre of Inflammation and Metabolism, Department of Infectious Diseases and CMRC, University Hospital Rigshospitalet, Copenhagen, Denmark

Received 12 October 2006/ Returned for modification 1 December 2006/ Accepted 14 January 2007

Systemic low-grade inflammation is recognized in an increasing number of chronic diseases. With the aim of establishing an experimental human in vivo model of systemic low-grade inflammation, we measured circulating inflammatory mediators after intravenous administration of Escherichia coli endotoxin (0.3 ng/kg of body weight) either as a bolus injection or as a 4-h continuous intravenous infusion, as well as after saline administration, in 10 healthy male subjects on three separate study days. Only bolus endotoxin caused an increase in heart rate, whereas a slight increase in rectal temperature was observed in both endotoxin groups. Tumor necrosis factor alpha (TNF-{alpha}), interleukin-6, and neutrophil responses were earlier and more pronounced in the bolus trial compared with the infusion trial results, whereas lymphocytes increased after endotoxin bolus injection as well as infusion without any difference between groups. Finally, endotoxin activated the hypothalamo-pituitary-adrenal axis slightly earlier in the bolus compared to the infusion trial. The continuous endotoxin infusion model may be more representative of human low-grade inflammation than the bolus injection model due to a less dynamic and more sustained increase in circulating levels of inflammatory mediators over time. In conclusion, low-dose endotoxin infusion elicits an inflammatory response, as assessed by a rise in TNF-{alpha}, and the responses are significantly different according to whether low-dose endotoxin is applied as a bolus injection or as a continuous infusion.

* Corresponding author. Mailing address: Centre of Inflammation and Metabolism, Rigshospitalet—Section 7641, Blegdamsvej 9, DK-2100 Copenhagen, Denmark. Phone: 45 35 45 86 09. Fax: 45 35 45 76 44. E-mail: sarahtaudorf{at}dadlnet.dk.

{triangledown} Published ahead of print on 31 January 2007.

Clinical and Vaccine Immunology, March 2007, p. 250-255, Vol. 14, No. 3
1071-412X/07/$08.00+0     doi:10.1128/CVI.00380-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Petersen, A. M., Plomgaard, P., Fischer, C. P., Ibfelt, T., Pedersen, B. K., van Hall, G. (2009). Acute Moderate Elevation of TNF-{alpha} Does Not Affect Systemic and Skeletal Muscle Protein Turnover in Healthy Humans. J. Clin. Endocrinol. Metab. 94: 294-299 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»